Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (1)
  • 2023 (8)
  • 2022 (11)
  • 2021 (6)
  • 2020 (3)
  • 2019 (2)

Subject

  • Drug Trafficking (409)
  • Synthetic drugs (186)
  • Guns/Weapons (108)
  • Overdose (55)
  • Arrests/Convictions - Major (54)
  • Gangs (53)
  • Prescription Drugs (49)
  • Guilty Plea (48)
  • Diversion Division (37)
  • Task Forces/Task Force Officers (30)
  • HIDTA (28)
  • Major Law Enforcement Operation (26)
  • OCDETF/Task Force (26)
  • Seizures (Drugs/Property) (24)
  • Fake Pills (20)
  • Money Laundering (19)
  • Take Back Day (16)
  • Fentanyl Awareness (9)
  • Press Conferences (8)
  • Extraditions (7)
  • Terrorism (7)
  • International/Foreign Operations (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Public and Media Affairs - also see Congressional Affairs (6)
  • Dark Web- Internet Trafficking (5)
  • Outreach/Drug Prevention (5)
  • One Pill Can Kill (2)
  • El Paso Intelligence Center (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (32)

Drug Name

  • Oxycodone (10)
  • Fentanyl (2)
  • Cocaine (1)
  • Ketamine (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • El Paso (9)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • New York (21)
  • New Jersey (11)
Clear All Results
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 19, 2025
NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
Noviembre 19, 2025
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

Abril 10, 2024
NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
Abril 10, 2024
PRESS RELEASE

Fort Salonga Urologist and Wife Charged with Criminal Sale of a Prescription for a Controlled Substance and Falsifying Business Records

Diciembre 14, 2023
SUFFOLK COUNTY, N.Y. – Suffolk County District Attorney Raymond A. Tierney and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III today announced the indictment of Francis and Jessica Martinis, of Fort Salonga, accused of Criminal Sale of Prescription for a Controlled Substance by a Practitioner and Falsifying...
Diciembre 14, 2023
PRESS RELEASE

Queens Pharmacist Sentenced to 60 Months in Prison for Illegally Distributing Oxycodone and Filing False Tax Returns

Noviembre 29, 2023
BROOKLYN, N.Y. - Today, Daniel E. Russo was sentenced to 60 months in prison by United States District Judge Dora L. Irizarry for conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. In...
Noviembre 29, 2023
PRESS RELEASE

Nurse Practitioner Arrested, Charged with Selling Oxymorphone

Octubre 05, 2023
BUFFALO, N.Y. - U.S. Attorney Trini E. Ross announced today that Michael Ostolski, 55, of North Tonawanda, NY, was arrested and charged by criminal complaint with conspiracy to distribute oxymorphone. The charge carries a maximum penalty of 20 years in prison and a $1,000,000 fine. Assistant U.S. Attorney Michael J...
Octubre 05, 2023
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

Octubre 04, 2023
NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
Octubre 04, 2023
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

Julio 27, 2023
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
Julio 27, 2023
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

Junio 22, 2023
ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
Junio 22, 2023
PRESS RELEASE

Queens Pharmacist Pleads Guilty to Illegally Distributing Oxycodone and Filing False Tax Returns

Febrero 17, 2023
BROOKLYN – Daniel E. Russo pleaded guilty today in federal court in Brooklyn to conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. The proceeding was held before United States District Judge Dora...
Febrero 17, 2023
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

Febrero 15, 2023
NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
Febrero 15, 2023
Showing 1 - 10 of 32 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster